Castle Biosciences (CSTL) Short Interest Ratio & Short Volume → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free CSTL Stock Alerts $24.67 -0.27 (-1.08%) (As of 11:39 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Castle Biosciences Short Interest DataCurrent Short Interest1,440,000 sharesPrevious Short Interest1,460,000 sharesChange Vs. Previous Month-1.37%Dollar Volume Sold Short$30.37 millionShort Interest Ratio5.8 Days to CoverLast Record DateApril 30, 2024Outstanding Shares27,610,000 sharesPercentage of Shares Shorted5.22%Today's Trading Volume47,349 sharesAverage Trading Volume244,352 sharesToday's Volume Vs. Average19% Short Selling Castle Biosciences ? Sign up to receive the latest short interest report for Castle Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCSTL Short Interest Over TimeCSTL Days to Cover Over TimeCSTL Percentage of Float Shorted Over Time Ad Insiders ExposedTrade Like a CEO: Zero Losses?Traders that never lose. It’s not a fairytale. Don’t miss this exclusive broadcast with our host Dustin Pass and the Insider expert Steven PlaceClick To Access This Powerful Training Right Now! Castle Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,440,000 shares $30.37 million -1.4%N/A5.8 $21.09 4/15/20241,460,000 shares $28.08 million +2.1%N/A6.3 $19.23 3/31/20241,430,000 shares $31.67 million +0.7%N/A5.7 $22.15 3/15/20241,420,000 shares $26.77 million +17.4%N/A5.6 $18.85 2/29/20241,210,000 shares $21.85 million -3.2%N/A4.6 $18.06 2/15/20241,250,000 shares $31.10 million +0.8%5.0%5.5 $24.88 Get the Latest News and Ratings for CSTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Castle Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,240,000 shares $28.62 million +29.3%5.0%5.4 $23.08 1/15/2024958,800 shares $19.20 million +19.8%3.8%3.7 $20.03 12/31/2023800,300 shares $17.27 million -18.1%3.2%2.9 $21.58 12/15/2023977,300 shares $19.61 million -17.2%3.9%3.6 $20.07 11/30/20231,180,000 shares $23.59 million -9.2%4.7%4.7 $19.99 11/15/20231,300,000 shares $24.99 million -9.1%5.2%5.2 $19.22 10/31/20231,430,000 shares $22.34 million +28.8%N/A5.6 $15.62 10/15/20231,110,000 shares $13.74 million +11.6%N/A4 $12.38 9/30/2023994,800 shares $16.80 million +19.4%N/A3 $16.89 9/15/2023833,200 shares $14.41 million +16.2%N/A1.5 $17.30 8/31/2023716,800 shares $14.29 million -3.6%N/A1.1 $19.93 8/15/2023743,500 shares $13.97 million -14.1%N/A0.9 $18.79 7/31/2023865,500 shares $14.58 million +1.3%N/A1 $16.85 7/15/2023854,500 shares $13.63 million +32.2%N/A1.1 $15.95 6/30/2023646,400 shares $8.87 million -26.8%N/A0.9 $13.72 6/15/2023883,200 shares $11.83 million +16.4%N/A2 $13.40 5/31/2023758,600 shares $18.53 million -13.6%N/A2 $24.43 5/15/2023878,100 shares $20.69 million -11.0%N/A6 $23.56 4/30/2023986,400 shares $22.32 million +0.7%N/A6.9 $22.63 4/15/2023979,400 shares $22.11 million -4.9%N/A6.8 $22.58 3/31/20231,030,000 shares $23.40 million -2.8%N/A7.1 $22.72 3/15/20231,060,000 shares $24.01 million +23.0%N/A6.8 $22.65 2/28/2023862,000 shares $21.71 million -25.0%N/A5.6 $25.18 2/15/20231,150,000 shares $30.94 million +4.6%N/A7.8 $26.90 1/31/20231,100,000 shares $29.79 million -2.7%N/A6.4 $27.08 1/15/20231,130,000 shares $30.75 million -5.0%N/A6 $27.21 12/30/20221,190,000 shares $28.01 million +5.3%4.9%5.9 $23.54 12/15/20221,130,000 shares $27.90 million +5.6%4.6%5.6 $24.69 11/30/20221,070,000 shares $25.24 million +0.9%4.4%5.3 $23.59 11/15/20221,060,000 shares $24.41 million -9.4%4.3%5.3 $23.03 10/31/20221,170,000 shares $29.86 million -10.0%4.8%5.9 $25.52 10/15/20221,300,000 shares $28.63 million +4.0%5.3%6.6 $22.02 9/30/20221,250,000 shares $32.60 million +7.8%5.3%6.3 $26.08 9/15/20221,160,000 shares $32.97 million -1.7%4.9%4.9 $28.42How this is some devastating news (Ad)Check out this report real quick… It’s full proof that most people barely have enough money to cover the monthly expenditures… Let alone save for retirement or plan the next vacation. At the risk of sounding political… If you’re waiting for the Fed, or the government or some financial advisor to come to change things for the better… You might be waiting for a long long time. But what if…? What if there was a way to completely turn the tables?But I can promise that you’ll see all the details for yourself here. 8/31/20221,180,000 shares $34.22 million -1.7%5.0%4.5 $29.00 8/15/20221,200,000 shares $40.19 million -17.2%5.1%4.1 $33.49 7/31/20221,450,000 shares $40.54 million +10.7%6.1%4.5 $27.96 7/15/20221,310,000 shares $32.40 million -1.5%5.4%3.6 $24.73 6/30/20221,330,000 shares $29.19 million +1.5%5.5%3.1 $21.95 6/15/20221,310,000 shares $22.22 million +3.2%5.4%3.2 $16.96 5/31/20221,270,000 shares $28.28 million -1.6%5.4%3.6 $22.27 5/15/20221,290,000 shares $25.43 million -2.3%5.5%3.9 $19.71 4/30/20221,320,000 shares $29.49 million +8.2%5.8%4.3 $22.34 4/15/20221,220,000 shares $31.65 million -9.6%5.3%4.1 $25.94 3/31/20221,350,000 shares $60.56 million -6.9%5.9%6.2 $44.86 3/15/20221,450,000 shares $52.87 million -4.6%6.3%6.8 $36.46 2/28/20221,520,000 shares $65.80 million +4.1%6.7%6.6 $43.29 2/15/20221,460,000 shares $62.78 million +3.6%6.4%5.8 $43.00 1/31/20221,410,000 shares $60.98 million +19.5%6.2%5.3 $43.25 1/15/20221,180,000 shares $43.29 million +22.6%6.5%4.9 $36.69 12/31/2021962,800 shares $41.28 million -12.5%5.4%4.3 $42.87 12/15/20211,100,000 shares $45.44 million +5.8%6.2%5 $41.31 11/30/20211,040,000 shares $42.98 million +24.5%5.8%4.9 $41.33 11/15/2021835,200 shares $43.76 million -1.3%4.7%4.5 $52.40 10/29/2021846,200 shares $52.76 million -14.8%4.8%5 $62.35 10/15/2021992,900 shares $63.13 million -16.6%5.6%6.3 $63.58 9/30/20211,190,000 shares $79.14 million -4.0%6.7%7.5 $66.50 9/15/20211,240,000 shares $92.65 million -12.1%7.0%7 $74.72 8/31/20211,410,000 shares $108.19 million No Change8.0%7.5 $76.73 8/13/20211,410,000 shares $90.86 million +1.4%8.0%6.9 $64.44 7/30/20211,390,000 shares $97.09 million -6.7%7.9%6 $69.85 7/15/20211,490,000 shares $96.76 million -3.3%8.5%6.1 $64.94 6/30/20211,540,000 shares $112.93 million +14.9%8.8%6.1 $73.33 6/15/20211,340,000 shares $97.27 million -1.5%7.7%5.2 $72.59 5/28/20211,360,000 shares $81.50 million +8.8%7.8%4.8 $59.93 5/14/20211,250,000 shares $62.59 million -44.2%N/A4 $50.07 4/30/20212,240,000 shares $152.48 million +1.8%14.6%7.3 $68.07 4/15/20212,200,000 shares $150.79 million -7.2%14.3%7.1 $68.54 3/31/20212,370,000 shares $147.37 million +0.9%15.5%7.4 $62.18 3/15/20212,350,000 shares $150.85 million +54.6%N/A7.2 $64.19 2/26/20211,520,000 shares $113.22 million +7.0%N/A4.3 $74.49 2/12/20211,420,000 shares $133.76 million -4.1%N/A4.4 $94.20 1/29/20211,480,000 shares $101.39 million -2.6%9.3%4.6 $68.51 1/15/20211,520,000 shares $114.94 million -9.0%9.6%5.2 $75.62 12/31/20201,670,000 shares $114.91 million +44.0%11.3%6.1 $68.81 12/15/20201,160,000 shares $71.83 million -2.5%7.9%4.5 $61.92 11/30/20201,190,000 shares $52.92 million -4.0%8.4%6.2 $44.47 11/15/20201,240,000 shares $62.45 million -1.6%8.9%6.8 $50.36 10/30/20201,260,000 shares $59.36 million +22.3%9.1%7 $47.11 10/15/20201,030,000 shares $54.37 million +40.4%7.5%5.9 $52.79 9/30/2020733,800 shares $37.75 million +40.3%5.4%4.2 $51.45 9/15/2020522,900 shares $25.35 million -23.5%3.9%2.5 $48.48 8/31/2020683,200 shares $31.24 million -18.1%5.1%3.1 $45.73 8/14/2020834,000 shares $34.46 million -5.1%6.5%4 $41.32How this is some devastating news (Ad)Check out this report real quick… It’s full proof that most people barely have enough money to cover the monthly expenditures… Let alone save for retirement or plan the next vacation. At the risk of sounding political… If you’re waiting for the Fed, or the government or some financial advisor to come to change things for the better… You might be waiting for a long long time. But what if…? What if there was a way to completely turn the tables?But I can promise that you’ll see all the details for yourself here. 7/31/2020879,200 shares $34.04 million -6.5%7.0%3.9 $38.72 7/15/2020939,800 shares $40.38 million -15.3%7.6%4.1 $42.97 6/30/20201,110,000 shares $41.84 million -12.6%9.6%4.9 $37.69 6/15/20201,270,000 shares $47.02 million -1.6%13.0%6.7 $37.02 5/29/20201,290,000 shares $49.57 million +13.2%13.3%7 $38.43 5/15/20201,140,000 shares $40.36 million +17.0%12.0%6.1 $35.40 4/30/2020974,800 shares $29.73 million +12.2%10.3%6 $30.50 4/15/2020868,800 shares $25.79 million +1.9%9.2%5.5 $29.69 3/31/2020852,300 shares $25.10 million +35.8%9.0%5.4 $29.45 3/13/2020627,700 shares $17.61 million +38.9%6.7%3.5 $28.05 2/28/2020451,800 shares $11.65 million -0.8%4.8%3.7 $25.79 2/14/2020455,400 shares $13.37 million -0.4%4.9%4 $29.36 1/31/2020457,400 shares $12.27 million -14.3%4.9%3.9 $26.82 1/15/2020533,700 shares $16.14 million +50.3%5.8%4.5 $30.25 12/31/2019355,100 shares $10.61 million +34.5%3.8%3.1 $29.89 CSTL Short Interest - Frequently Asked Questions What is Castle Biosciences' current short interest? Short interest is the volume of Castle Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 1,440,000 shares of CSTL short. Learn More on Castle Biosciences' current short interest. What is a good short interest ratio for Castle Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CSTL shares currently have a short interest ratio of 6.0. Learn More on Castle Biosciences's short interest ratio. Which institutional investors are shorting Castle Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Castle Biosciences: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Castle Biosciences' short interest increasing or decreasing? Castle Biosciences saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 1,440,000 shares, a decrease of 1.4% from the previous total of 1,460,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Castle Biosciences' short interest compare to its competitors? Here is how the short interest of companies compare to Castle Biosciences: Fulgent Genetics, Inc. (3.48%), CareDx, Inc (10.57%), Celcuity Inc. (6.08%), Viridian Therapeutics, Inc. (14.59%), Sera Prognostics, Inc. (1.11%), Biodesix, Inc. (0.30%), Genetron Holdings Limited (0.08%), Personalis, Inc. (3.03%), Renalytix Plc (0.81%), Exagen Inc. (0.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Castle Biosciences stock? Short selling CSTL is an investing strategy that aims to generate trading profit from Castle Biosciences as its price is falling. CSTL shares are trading up $0.70 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Castle Biosciences? A short squeeze for Castle Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CSTL, which in turn drives the price of the stock up even further. How often is Castle Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CSTL, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: FLGT Short Interest Data CDNA Short Interest Data CELC Short Interest Data VRDN Short Interest Data SERA Short Interest Data BDSX Short Interest Data GTH Short Interest Data PSNL Short Interest Data RNLX Short Interest Data XGN Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CSTL) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersNext President (Not Trump. Not Biden.)The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Crypto for AIWeiss RatingsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersBill Gates is all about this tiny $2 stockTimothy SykesThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold